Review
Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
Affiliations
- PMID: 8420141
Item in Clipboard
Review
Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
Adv Neurol.
1993.
No abstract available
Similar articles
-
Metabolic aspects of the behavior of MPTP and some analogues.Adv Neurol. 1993;60:186-93. Adv Neurol. 1993. PMID: 8420134 Review. No abstract available.
-
Type B monoamine oxidase and neurotoxins.Eur Neurol. 1993;33 Suppl 1:31-7. doi: 10.1159/000118535. Eur Neurol. 1993. PMID: 8375430 Review.
-
(-)Deprenyl in perspective: prophylaxis for Parkinson's disease?J Neural Transm Suppl. 1986;22:107-15. J Neural Transm Suppl. 1986. PMID: 3097254
-
Pathogenesis and animal studies of Parkinson's disease.Curr Opin Neurol Neurosurg. 1993 Jun;6(3):323-32. Curr Opin Neurol Neurosurg. 1993. PMID: 8507901 Review.
-
Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.J Neurochem. 2005 Oct;95(1):79-88. doi: 10.1111/j.1471-4159.2005.03341.x. J Neurochem. 2005. PMID: 16181414
Cited by
-
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications.Antioxid Redox Signal. 2015 Nov 10;23(14):1171-85. doi: 10.1089/ars.2015.6433. Antioxid Redox Signal. 2015. PMID: 26583264 Free PMC article. Review.
-
Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.Int Rev Neurobiol. 2011;100:13-42. doi: 10.1016/B978-0-12-386467-3.00002-9. Int Rev Neurobiol. 2011. PMID: 21971001 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical